Micro-X (ASX:MX1) ROCE % : -82.38% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Micro-X ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Micro-X's annualized ROCE % for the quarter that ended in Dec. 2023 was -82.38%.

Micro-X ROCE % Historical Data

The historical data trend for Micro-X's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Micro-X ROCE % Chart

Micro-X Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROCE %

Get a 7-Day Free Trial

-276.71

-67.64

-43.02

-51.53

-44.83

Micro-X Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial												-48.15	-56.11	-28.37	-53.30	-82.38

Micro-X ROCE % Calculation

Micro-X's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	-10.485	/	( ( (31.277 - 6.479)	+	(30.298 - 8.318) )	/ 2 )
	=	-10.485	/	( (24.798	+	21.98)	/ 2 )
	=	-10.485	/	23.389
	=	-44.83 %

Micro-X's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-15.08	/	( ( (30.298 - 8.318)	+	(21.571 - 6.94) )	/ 2 )
	=	-15.08	/	( ( 21.98	+	14.631 )	/ 2 )
	=	-15.08	/	18.3055
	=	-82.38 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Micro-X (ASX:MX1) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Micro-X ROCE % Related Terms

Thank you for viewing the detailed overview of Micro-X's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Micro-X (ASX:MX1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Micro-X Ltd (ASX:MX1) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

MCRXF:USA

Address

1284 South Road, A14, 6 MAB Eastern Promenade, Tonsley, Clovelly Park, Adelaide, SA, AUS, 5042

Website

https://www.micro-x.com

Micro-X Ltd operates in the medical industry. The company operates in designs, develops, and manufactures ultra-lightweight carbon nanotube-based X-ray products for the healthcare and counter IED imaging security markets. Its product includes Nano; Rover and Mobile Backscatter Imager (MBI), Mobile Baggage Scanner (MBS), and others. Geographically, it derives a majority of revenue from Asia-Pacific and also has a presence in the United States and Europe.

Micro-X (ASX:MX1) Headlines

No Headlines